What’s next for CLTI treatment? Exclusive interview with Eric Secemsky at PVI 2024

In this exclusive PVI 2024 interview, Dr. Eric Secemsky discusses the evolving landscape of chronic limb-threatening ischemia (CLTI) care.

He highlights the latest trends in U.S. best practices, emphasizing the importance of evidence-based approaches in device selection and treatment planning.

With major trials like BEST-CLI confirming the effectiveness of endovascular interventions over surgery, current research is now focused on evaluating innovative technologies such as bioresorbable stents, drug-coated balloons, atherectomy, lithotripsy devices, and temporary stents.

Watch the full interview below to gain expert insights into the future of CLTI treatment and emerging therapeutic options!